Spencer Durham can be reached at 765-454-8598, by email at [email protected] or on Twitter at @Durham_KT.

The business strategies of companies involved in chiral drug development were cast into doubt in October after Eli Lilly (Indianapolis, IL) decided not to pursue the development of R-fluoxetine ...

There's a long list of companies. Maybe you put Lilly in the early 2000s on this list or even the Prozac years, that generate those kinds of excess returns. And then we look back and we say ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Eli Lilly's main revenue drivers are diabetes drugs and weight loss medication, specifically Mounjaro and Zepbound. It also manufactures antidepressants, most notably Prozac, and it's developing a ...

Later, Eli Lilly & Co introduced the bestselling SSRI drug, Prozac, which made Astra realise that if it had continued with its SSRI drug development it would probably have beaten Lilly to this ...

She’s racing to a run-through for a 14-course tasting menu she will barely nibble at as she raves about her weight loss on ...

Eli Lilly released the first selective serotonin reuptake inhibitor (SSRI), Prozac, in 1987, once again revolutionising mental health practice. The first statin was also approved in 1987 ...

Johnson & Johnson agreed to acquire mental-illness drug developer Intra-Cellular Therapies for about $15 billion, evidence of the pharmaceutical industry’s renewed interest in neuroscience bets ...

The Kokomo woman was pre-diabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed ...

[8] In the 1950s, pharmaceutical company Eli Lilly, later known for producing the antidepressant Prozac and antipsychotic Zyprexa, was the primary supplier of LSD in “tonnage quantities” for CIA ...

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.